INTRODUCTION
The adult central nervous system (CNS) has a limited capacity for self-repair after neuronal loss caused by trauma or disease. Neurogenesis continues into adulthood within certain regions of the adult vertebrate brain, such as the anterior subventricular zone (SVZ) and the hippocampal dentate gyrus (1, 14, 19, 31, 43, 60) . However, in response to injury, the multipotential neural precursors that reside in these areas proliferate and differentiate mainly into astrocytes and not neurons (18, 20, 38) . At present, cell transplantation is the only means by which CNS neurons can be replaced, although the potential for inducing endogenous CNS stem cells to neuronal differentiation may prove feasible (9, 27, 33) . Multipotent neural stem cells, defined by their ability to proliferate, self-renew, and retain the potential to differentiate into both neurons and glia, have been isolated from both the embryonic and the adult brain and spinal cord (4, 10, 12, 16, 21, 22, 28, 44, 45, 48, 57, 62) . These cells can be expanded through multiple passages in vitro in the presence of appropriate mitogens, FGF2 or EGF, or both, to produce a large number of cells for transplantation (16, 27, 47, 56) . Importantly, they retain their multipotentiality (33, 46, 47) . The multipotential neural stem cells can also be induced in vitro to produce enriched proportions of glial or neuronal progenitors using defined extrinsic factors. Such conditions may potentially allow for the design of cellular transplants that can fulfill specific needs in the repair of the damaged CNS (5, 37) . Disappointingly, most of these cells showed glial-restricted differentiation after being engrafted into the adult CNS, especially into nonneurogenic areas or injured CNS (7, 8, 13) . It was only when these stem cells were transplanted into the developing brain, or the areas in the adult brain undergoing active neurogenesis, that significant numbers differentiated into region-appropriate neurons (6, 12, 13, 55) . Taken together, these studies indicate that the host environment plays very important roles in determining the fate of engrafted stem cells.
There is also evidence suggesting that the intrinsic state of the grafted cell may play a critical role in its fate determination (63) . Differences between neural progenitor cells isolated from different brain regions exist (2, 46) . For example, neuronal-restricted precursors (NRPs) derived from the embryonic spinal cord migrated extensively and generated a variety of different morphologies and neurotransmitter neuronal phenotypes after transplantation into the SVZ (67) . However, the SVZ NRPs showed limited migration and differentiation potential in the same area (68) . More interestingly, spinal cord-derived NRPs differentiated into neurons expressing choline acetyltransferase (ChAT) in the brain areas where endogenous ChATpositive neurons have not been found, suggesting that cell autonomous mechanisms in some engrafted progenitors committed them to a restricted phenotype even after ectopic engraftment.
Previous work showed that pluripotent neural stem cells isolated from E14 cortex (7) or embryonic (8) or adult (55) spinal cord differentiated into only glia after engraftment into the normal and injured spinal cord. These data suggested that the in vitro induction of these pluripotent cells into more restricted progenitor cells prior to transplantation may be necessary for their neuronal differentiation in adult spinal cord. NRPs are more restricted progenitor cells, as they will differentiate into only neurons in vitro (34, 37) . More importantly, NRPs isolated from spinal cord can differentiate into the major neuronal phenotypes found in the adult (23) . These cells may thus be an ideal candidate for cell transplantation to replace neurons lost after spinal cord injury. The present study tested that hypothesis.
MATERIALS AND METHODS

Preparation of NRPs in vitro.
NRPs were immunopanned from E14 Fisher 344 rat spinal cord using an E-NCAM antibody and a protocol modified from previous studies (23, 34) . Briefly, embryos were removed and placed in a petri dish containing L15 medium (Life Technologies/BRL). Spinal cords were mechanically dissected from the surrounding connective tissue with sharpened No. 5 forceps. Isolated spinal cords were incubated in 0.05% trypsin solution for 30 min at 4°C. The trypsin solution was replaced with growth medium consisting of DMEM-F12 (Life Technologies/BRL) supplemented with N2 supplement, FGF2 (20 ng/ml), and NT3 (10 ng/ml). The segments were gently triturated into a single-cell suspension with a fire-polished Pasteur pipette. The glial-restricted precursors in the cell suspension were removed by incubation on an A2B5 antibody-coated dish to allow binding of all A2B5-positive cells to the plate. The remaining nonadherent cells were immunopanned on dishes coated with antibody against polysialated (PS) NCAM to isolate NRPs. PS-NCAM antibody-coated dishes were prepared by sequentially coating petri dishes with an unlabeled anti-mouse IgM antibody (10 g/ml) overnight and rinsing the dishes with DPBS, followed by coating with PS-NCAM hybridoma supernatant (5A5; DSHB) for 1-3 h at room temperature. Cells were allowed to bind for 1 h at room temperature. Unbound cells were removed and the plates were rinsed eight times with DPBS. Bound cells were mechanically scraped off and plated in growth medium on fibronectin/laminincoated dishes. Medium was changed every other day and growth factors were added daily. In all cases, an aliquot of cells was analyzed the next day to determine the efficiency of the immunopanning. Only those cell preparations in which Ͼ90% of the bound cells expressed PS-NCAM were used in the experiments. After about 5 days, the cells were passaged at 60 -70% confluence by brief incubation in HBSS (Ca 2ϩ and Mg 2ϩ free) and dislodging with a cell lifter. The cells were replated on fibronectin/laminin-coated dishes at a density of 3 ϫ 10 5 /100-mm plate. To differentiate NRPs in vitro, the cells were plated in polyorthine/fibronectin-coated six-well plates. The following day, the FGF2 was removed and 1 M retinoic acid was added to the growth medium. The differentiating medium was changed every other day. After 6 days, the cells were fixed and assessed by immunohistochemical analysis for their differentiated phenotypes.
Before transplantation, NRPs were labeled either by bromodeoxyuridine (BrdU) or by infection with retrovirus expressing enhanced green fluorescent protein (EGFP). For BrdU labeling, undifferentiated P2 NRPs were incubated in 10 M BrdU overnight. This resulted in over 90% labeling efficiency and did not result in any loss of cell viability. For retroviral labeling, NRPs were treated with 1 g/ml polybrene for 1 h, followed by incubation in growth medium containing LZRS-EGFP retrovirus for 4 h. Routinely, about 60% cells were labeled. Two hours before transplantation, the labeled cells were detached from the dishes using a cell lifter, collected by centrifugation at 1000g min, and resuspended in 1 ml culture medium. After cell counting and viability assessment with trypan blue and a hemacytometer, the cell suspension was centrifuged a second time and resuspended in a smaller volume to give a density of 5 ϫ 10 4 viable cells/l. Surgical procedures. The care and treatment of all animals were in strict accordance with NIH and University of Louisville IACUC guidelines. Thirty adult female Fisher 344 rats (170 -200 g) were divided into two groups: NRPs transplanted into the normal spinal cord and NRPs transplanted into the T8 contused spinal cord. The animals survived 2 weeks, 1 month, and 2 months, after transplantation. Twelve more rats were grafted at the hippocampus and cortex, and the animals were sacrificed at 2, 4, and 8 weeks posttransplantation.
The contusion and transplantation procedures were performed as described previously (7, 66) . To graft stem cells into the normal spinal cord, rats were anesthetized with ketamine (0.8 mg/kg, ip) and xylazine (0.5 mg/kg, ip), a T 8 dorsal laminectomy was performed, and the T 7 and T 9 spinous processes were rigidly fixed in a spinal frame. A small parasagittal incision was made in the exposed dura overlying the dorsal surface of the spinal cord. Three microliters of labeled NRPs (1.5 ϫ 10 5 cells) were injected unilaterally into the white matter in the ventral column and the gray matter in the ventral horn through a glass micropipette with an outer diameter of 50 -70 m and the tip sharp-beveled to 30 -50°. The microinjection system was powered by compressed 90% O 2 :5% CO 2 (66) . The muscle and skin were sutured and lactated Ringer's solution and antibiotics administered to prevent dehydration and infection. For stem cell grafts into the injured spinal cord, rats were prepared as described above, and 12.5 g-cm NYU Impactor contusion lesions were performed (7). Ten days postinjury, the spinal cord was reexposed and a small window opened in the dura. Three microliters of cells (5 ϫ 10 4 cells/l) was stereotactically injected unilaterally into the gray matter one segment rostral (T 7 ) and caudal (T 9 ) to the lesion epicenter (T 8 ).
A total of nine animals were used for the transplantation of NRPs into hippocampus. The animals were anesthetized as described above. After craniotomy, the exposed dura was cut over the transplantation site and the animals were stabilized in the stereotaxis instrument. Three microliters of either BrdU-or GFP-labeled NRPs (1.5 ϫ 10 5 cells) were unilaterally injected into the hippocampus at the site 2.4 mm lateral to midline, 4.0 mm posterior to bregma, and 2.1-2.7 mm below the dura. Three animals in each group were perfused at 2 weeks, 1 month, or 2 months posttransplantation and the sections of hippocampus were processed for immunohistochemical analysis.
Immunohistochemistry. Immunostaining of cells differentiated in vitro was performed as described previously (6, 7, 66) using monoclonal mouse antiMap2a,b (1:40; Sigma, St. Louis, MO), monoclonal mouse anti-␤III-tubulin (1:100; Sigma), monoclonal mouse anti-nestin (1:10; DSHB, Iowa City, IA), monoclonal mouse anti-160-kDa neurofilament M (NF-M; 1:100; Sigma), polyclonal rabbit anti-glutamate (1:100; Signature Immunologics, Salt Lake City, UT), polyclonal rabbit anti-glycine (1:100; Signature Immunologics), polyclonal rabbit anti-GABA (1:500; Sigma), and polyclonal goat anti-ChAT (1:20; Chemicon, Temecula, CA) antibodies. The specificity of staining was evaluated by substituting primary antibodies with normal mouse or sheep serum. No positive labeling was observed in the negative controls.
For the histological analysis of the grafted cells, rats were anesthetized with 80 mg/kg nembutal and perfused transcardially with 0.1 M PBS (pH 7.4), followed by 4% paraformaldehyde in 0.1 M PB. The spinal cord segments that received the grafts were removed, cryoprotected in 30% sucrose buffer overnight at 4°C, embedded in OCT compound, and transversely sectioned at 10 m on a cryostat. Sections were mounted on Fisher positively charged slides and stored at Ϫ80°C. For BrdU charged staining, the slides were warmed for 20 min, treated in 2 N HCl for 30 min at room temperature (RT), and rinsed in borate buffer and 0.1 M Tris-buffered saline (TBS), each for 10 min. These steps were omitted for sections containing EGFP-labeled NRPs. After being blocked with 10% donkey serum in TBS containing 0.3% Triton X-100 (TBST) for 1 h at RT, the sections were incubated in TBST containing 5% donkey serum and either polyclonal sheep antiBrdU (1:100; Chemical International) or polyclonal chick anti-GFP (1:500; Chemicon) with one of the following antibodies: monoclonal mouse anti-NeuN (1:200), monoclonal mouse anti-␤III-tubulin (1:100; Sigma), monoclonal mouse anti-Map2a,b, monoclonal mouse anti-GFAP (1:200), polyclonal rabbit anti-GAD (1:200; Chemicon), monoclonal mouse anti-nestin (1:10), or monoclonal MBP (1:50; Chemicon) overnight at 4°C. After three washes of 10 min in TBS, the sections were incubated in TBST containing 5% donkey serum, donkey anti-sheep or donkey anti-chick FITC-conjugated FabЈ fragments (1:100; Jackson ImmunoResearch Lab, Baltimore, MD), and donkey anti-mouse Texas redconjugated FabЈ fragments (1:200; Jackson ImmunoResearch Lab) for 1 h at RT. The sections were rinsed in TBS and coverslipped with antifade mounting medium (Molecular Probes, Eugene, OR). Fluorescence (Nikon Eclipse TE300 inverted microscope equipped with RT color Spot camera) and confocal microscopy (Zeiss Axiophot; LSM 510) were used to capture representative images. Photomicrographs were assembled using Adobe PhotoShop and Adobe Illustrator software.
RESULTS
NRP differentiation in vitro.
Proliferating NRPs could be expanded through multiple passages (up to P11, the latest passage examined) and retained their proliferating and differentiated properties. Similar to data described by Rao and colleagues (23, 34) , proliferating NRPs were nestin-positive; some expressed ␤III-tubulin, an immature neuronal marker, while very few cells expressed the mature neuronal marker NF-M (data not shown). After growth in differentiating medium for 6 days, virtually all of the NRPs differentiated into neurons, as shown by the expression of ␤III-tubulin (Figs. 1A and 1B) and NF-M (Figs. 1C and 1D ). To examine if the NRPs were capable of differentiation into the major neuronal phenotypes found in the adult spinal cord, differentiated NRPs were evaluated for the expression of GABA, glycine, glutamate, and ChAT. The majority of differentiated NRPs expressed GABA (Figs. 1E and 1F) . Some of them were glutamatergic (Figs. 1G and 1H) or glycinergic (Figs. 1I and 1J ). There were also a few cells expressing ChAT (Figs. 1K  and 1L ). These cells usually appeared in clumps, rather than being distributed evenly throughout dish.
NRP differentiation in the adult normal spinal cord.
The engrafted progenitors, detected by GFP immunohistochemistry, survived in all the rats at all posttransplantation times: 2 weeks, 1 month, and 2 months. The cells were observed up to 1.8 mm rostral and caudal from the injection site. The NRPs showed different neuronal morphologies after transplantation into normal spinal cord (Fig. 2) . The majority of the engrafted NRPs were multipolar with long processes. Some were small and round with short processes, and bipolar morphology with elongated cell body was also observed.
Most NRPs expressed ␤III-tubulin (Figs. 3A-3C ). The percentage of ␤III-tubulin-positive cells 2 weeks, 1 month, and 2 months after engraftment was 56, 58, and 62%, respectively (Table 1) . Some engrafted NRPs expressed GAD (Figs. 3D-3F) . A small number of cells were also positive for glutamate (Figs. 3G-3I) and ChAT (Figs. 3J-3L ).
NRP differentiation in the contused adult spinal cord.
The engrafted NRPs survived in all of the injured animals. BrdU-labeled cells were found both in
FIG. 1. NRP differentiation in vitro. After differentiating for 6 days, almost all the cells expressed the neuronal markers ␤III-tubulin (A, B) and NF-M (C, D). A large number of cells also expressed GABA (E, F) and glutamate (G, H). Some were glycine-positive (I, J). A small number of cells were ChAT-positive (K, L). Magnification bar, 100 m (A-L).
the cavities and in the areas surrounding the cavities. Double-staining experiments with BrdU and the different neuronal markers demonstrated that the neuronal differentiation of engrafted NRPs was restricted in the injured spinal cord. Only a small number of NRPs expressed either Map2a,b (Figs. 4A-4C ) or ␤III-tubulin (Figs. 4D-4F ). As shown in Table 1 , the proportion of ␤III-tubulin-positive cells is 11, 10, and 13%, respectively, at 2 weeks, 1 month, and 2 months posttransplantation, compared to 56, 58, and 62% in the normal spinal cord at the same times postgraft. Some engrafted cells were still nestin-positive, suggesting that these cells remained undifferentiated (Figs. 4G-4I ). The percentage of nestin-positive cells 2 weeks, 1 month, and 2 months posttransplantation is 19, 17, and 16%, respectively ( Table 1 ). The majority of cells, which lost nestin expression, did not express more mature lineage markers. Neither the neurotransmitters GABA, glutamate, and ChAT nor the more mature neuronal markers NeuN and NF-160 were expressed in the engrafted NRPs (data not shown).
We have previously shown that in the injured spinal cord, there are predominant signals that induce pluripotent neural stem cells to differentiate into only astrocytes (7). To assess if these signals reprogrammed the engrafted NRPs to become glia, the expression of GFAP and MBP by NRPs was examined immunohistochemically. Although there was very strong GFAP expression in the injured spinal cord, especially in the epicenter, the morphology of the engrafted NRPs was very different from that of GFAP-positive astrocytes, and colocalization of GFP and GFAP was not detected (Figs. 5A-5C ). Similarly, coexpression of GFP and MBP was not found in the engrafted NRPs (Figs. 5D-5F ).
NRP differentiation in the normal adult hippocampus. To access the differentiated potential in the areas other than spinal cord, NRPs were engrafted into the adult rat hippocampus. In the dentate gyrus, the engrafted NRPs showed mature neuronal morphology with robust processes. Some engrafted NRPs in CA1 had morphologies resembling pyramidal neurons (Figs. 6A and 6B ). Most NRPs expressed the mature neuronal marker NeuN (Figs. 6C-6E ). To assess if the engrafted cells adapted appropriate phenotypes in these area, their expression of calbindin was examined. As shown in Figs. 6F-6H, the engrafted NRPs also expressed calbindin, a protein that was not expressed by NRPs in vitro (data not shown).
DISCUSSION
NRPs derived from E14 spinal cord can proliferate through multiple passages in the presence of FGF2 and NT3 and differentiate in vitro into the major types of neurons found in the adult spinal cord without becoming glia; these data are consistent with previous studies (23, 34) . After transplantation into the adult normal spinal cord, robust survival was observed. More importantly, the grafted cells differentiated into neurons and expressed the neurotransmitters GABA, glutamate, and ChAT. Similar results have been reported by Fisher and colleagues (17a). These results suggest that the adult spinal cord is permissive for or has the Note. Data represent the means Ϯ SEM of the percentages of either BrdU-or GFP-labeled NRPs in a given microscopic field that express one of the indicated antigens, ␤III-tubulin or nestin. Twenty fields from 20 randomly chosen sections from three independent animals were used to calculate the percentages. The number of total cells/field averaged 76 Ϯ 25. The percentage of ␤III-tubulin-positive cells changed significantly along different postgraft times in both normal and injured spinal cord (ANOVA single factor, normal cord, F ϭ 5.94, df ϭ 2, P Ͻ 0.001; injured cord, F ϭ 11.02, df ϭ 2, P Ͻ 0.001), as well as the percentage of nestin-positive cells (normal, F ϭ 8.93, df ϭ 2, P Ͻ 0.001; injured cord, F ϭ 6.41, df ϭ 2, P Ͻ 0.01). Student-Newman-Keuls post hoc t test revealed that the percentage of ␤III-tubulinpositive cells in the normal cords was significantly higher than that in the injured cords at each postgraft time point (all P Ͻ 0.001). However, the percentage of nestin-positive cells in the normal cords was significantly lower than that in the injured cords at each postgraft time point (all P Ͻ 0.001). potential to induce NRP differentiation into different types of neurons. Recent work engrafting rodent neural stem cells isolated from E14 cortices (7) and embryonic (8) or adult (55) spinal cord into the adult normal and contused injured spinal cord showed that these stem cells differentiated into only glia and not neurons.
There is increasing evidence suggesting that the intrinsic states of grafted cells play very important roles in determining their differentiation potential. The neuronal differentiation of the NRPs grafted into the normal adult spinal cord reflects the neuronal commitment of NRPs. The epigenetic signals in the normal adult spinal cord that direct glial differentiation of grafted pluripotentent stem cells cannot override that neuronal commitment. NRPs derived from different origins showed distinct differentiation potential after transplantation into CNS (2, 46) . For example, when SVZ progenitors, which normally generate only interneurons of the olfactory bulb, are transplanted into the embryonic nervous system, they do not give rise to long projection neurons at places and times when such neurons are normally being generated from endogenous progenitor cells (31) . The cells from the same source but different developmental stages also showed dra- matic differences in their lineage potential. For example, undifferentiated neural stem cells did not neuronally differentiate after engraftment into the lesioned striatum. But, if stem cells were differentiated 5 days in vitro prior to transplantation, the engrafted cells survived and both neuronal and astrocytic differentiation was observed (59) . Similarly, undifferentiated neural precursor cells engrafted into the adult neocortex after pyramidal neurons were induced to degenerate failed to undergo neuronal differentiation, but some astrocytic differentiation was observed. However, if the later stage precursors and immature neurons were transplanted into such area, the engrafted cells were found to follow pyramidal neuron differentiation (17, 51, 52) . These more mature later stage precursor cells likely acquire the expression of specific receptors and/or intracellular effector pathways that enable them to respond to host-derived signals and differentiate with mature, area-specific neuronal phenotype.
The engrafted NRPs differentiated into neurons after transplantation into the hippocampus and, importantly, were induced to express calbindin in the dentate gyrus. The hippocampus and the SVZ are neurogenic areas, where neurogenesis persists through adulthood (14, 15) . Engrafted NRPs were able to respond to the relevant neurogenic signals in these areas to undergo this site-specific neuronal differentiation. This result is in agreement with previous grafting experiments, which showed that NRPs transplanted into the SVZ migrated extensively along the intrinsic migratory pathway in the rostral migratory stream and underwent site-specific differentiation in the olfactory bulb, although some differences between NRPs from the spinal cord and SVZ were observed (67) . Many adult spinal cord neural progenitor cells engrafted into the hippocampus became calbindin-expressing neurons (55) . In vitro, the multipotential progenitors can be induced to differentiate into different lineages by using different growth factors (21, 65) . In vivo, the same neural stem cells showed different differentiation potential after transplantation into different areas in the developing or adult CNS (6, 13, 53) . Collectively, these data indicate that both extrinsic and intrinsic signals interact to regulate the neuronal differentiation and that the developmental state of the engrafted precursors is crucial to understanding how these cells will differentiate (34) .
In contrast to grafts into the normal spinal cord, NRP grafts into the injured spinal cord remained undifferentiated or partially differentiated, characterized by a loss of nestin immunoreactivity with but a few neurons observed. These data indicate that the microenviromental signals in the injured spinal cord can inhibit the constitutive differentiation of the grafted NRPs. This result is consistent with previous studies. For example, the immortalized neuronal precursor cell line RN33B differentiated with variable complex neuronal phenotypes after transplantation into the intact adult spinal cord. However, this differentiation was inhibited in the injured spinal cord (39, 40) . Similarly, the neuronal differentiation of RN33B cells in the injured hippocampus (54) and striatum (33) was also inhibited. More recently, we found that the differentiation of neural stem cells in the contused spinal cord was delayed and more stem cell remained undifferentiated (7) .
Changes in the activation state of microglia and macrophages (25, 26) , expression of various neurotrophic factors (35, 43) , and levels of neurite growth-inhibitory molecules (49, 50) are all dramatically altered in the traumatically injured spinal cord. These changes likely have complicated, synergistic, and/or antagonistic effects on NRPs differentiation in vivo. Importantly, both ciliary neurotrophic factor (30, 42) and leukemia inhibitory factor (3, 29) are markedly upregulated following CNS injury. These factors were strong extrinsic signals to prevent neuronal differentiation and induce the neural stem cells to differentiate along astrocytic lineage (21, 24, 65) . In the injured spinal cord, these glialdifferentiating signals may be dominant over the neuronal differentiation signals and possibly to contribute to the inhibition of the NRP cell neuronal differentiation. However, glial differentiation of the engrafted NRPs was not observed in the injured spinal cord, indicating that these signals cannot override the cell autonomous lineage potential of the NRPs. In vitro, we have observed a hierarchy of growth factor regulation of stem cell differentiation, consistent with these present results (P. Tsoulfas and S. R. Whittemore, unpublished results). The fact that most NRPs in the injured spinal cord remain undifferentiated or partially differentiated suggests that they retain their potential for their neuronal differentiation. Further manipulation of the environment of the injured spinal cord will be necessary to facilitate the neuronal replacement by NRPs in this injury. Exactly how to manipulate the injured spinal cord to facilitate that neuronal differentiation remains to be elucidated. While stem cell grafting remains the most viable approach to replace lost neurons, it is very likely that different types of CNS neurons will require very precise combinations of stem cell lineage induction and host modification to enable cell-type-specific differentiation in vivo, making this a potentially challenging clinical therapeutic strategy. 
